A rating of 88 puts Prothena Corporation PLC (PRTA) near the top of the Biotechnology industry according to InvestorsObserver. Prothena Corporation PLC's score of 88 means it scores higher than 88% of stocks in the industry. Prothena Corporation PLC also received an overall rating of 73, putting it above 73% of all stocks. Biotechnology is ranked 16 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Prothena Corporation PLC (PRTA) stock has gained 16.88% while the S&P 500 is down 0% as of 10:19 AM on Friday, Feb 12. PRTA is up $2.65 from the previous closing price of $15.70 on volume of 238,634 shares. Over the past year the S&P 500 has risen 16.07% while PRTA is up 42.03%. PRTA lost -$2.78 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Prothena Corporation PLC (PRTA) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

See more here:
Is Prothena Corporation PLC (PRTA) a Winner in the Biotechnology Industry? - InvestorsObserver